• Case-Based Roundtable
  • General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Chronic Spontaneous Urticaria
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis
  • Buy-and-Bill

Article

Severe skin reactions linked to ocular damage

Author(s):

Rouen, France ?Patients with toxic epidermal necrolysis (TEN) or Stevens-Johnson syndrome (SJS) commonly experience acute ocular involvement, according to a study published in the Archives of Dermatology.

Rouen, France

- Patients with toxic epidermal necrolysis (TEN) or Stevens-Johnson syndrome (SJS) commonly experience acute ocular involvement, according to a study published in the

Archives of Dermatology

.

Researchers studied 159 patients (mean age, 49.9 years), who had TEN and SJS, and had been out of the hospital for at least 15 months.

They found that acute ocular involvement was common, occurring in 117 (74 percent) of the patients, with 58 percent having mild symptoms and 8 percent each having moderate or severe symptoms, according to HealthDay News.

Investigators also found that patients with TEN were more likely to have ocular involvement than those with SJS, though the severity of the symptoms was similar, according to the investigators. Of 49 patients interviewed at least 15 months after discharge, 63 percent had late ocular complications, according to HealthDay.

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Related Videos
1 expert in this video
1 expert in this video
1 expert in this video
1 expert in this video
1 expert in this video
4 experts are featured in this series.
4 experts are featured in this series.
2 experts in this video
© 2025 MJH Life Sciences

All rights reserved.